Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 296

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Open access
Sarin, Shiv Kumar, Choudhury, Ashok, Lau, George K., Zheng, Ming-Hua, Ji, Dong, Abd-Elsalam, Sherief, Hwang, Jaeseok, Qi, Xiaolong, Cua, Ian Homer, Suh, Jeong Ill, Park, Jun Gi, Putcharoen, Opass, Kaewdech, Apichat, Piratvisuth, Teerha, Treeprasertsuk, Sombat, Park, Sooyoung, Wejnaruemarn, Salisa, Payawal, Diana A., Baatarkhuu, Oidov, Ahn, Sang Hoon, Yeo, Chang Dong, Alonzo, Uzziel Romar, Chinbayar, Tserendorj, Loho, Imelda M., Yokosuka, Osamu, Jafri, Wasim, Tan, Soeksiam, Soo, Lau Ing, Tanwandee, Tawesak, Gani, Rino, Anand, Lovkesh, Esmail, Eslam Saber, Khalaf, Mai, Alam, Shahinul, Lin, Chun-Yu, Chuang, Wan-Long, Soin, A. S., Garg, Hitendra K., Kalista, Kemal, Batsukh, Badamnachin, Purnomo, Hery Djagat, Dara, Vijay Pal, Rathi, Pravin, Al Mahtab, Mamun, Shukla, Akash, Sharma, Manoj K., Omata, Masao, APASL COVID Task Force, APASL COVID Liver Injury Spectrum Study (APCOLIS Study-NCT 04345640)·2020·Hepatology International

Abstract

Background and aims COVID-19 is a dominant pulmonary disease, with multisystem involvement, depending upon comorbidities. Its profile in patients with pre-existing chronic liver disease (CLD) is largely unknown. We studied the liver injury patterns of SARS-Cov-2 in CLD patients, with or without cirrhosis. Methods Data was collected from 13 Asian countries on patients with CLD, known or newly diagnosed, with confirmed COVID-19. Results Altogether , 228 patients [185 CLD without cirrhosis and 43 with cirrhosis] were enrolled, with comorbidities in nearly 80%. Metabolism associated fatty liver disease (113, 61%) and viral etiology (26, 60%) were common. In CLD without cirrhosis, diabetes [57.7% vs 39.7%, OR = 2.1 (1.1–3.7), p = 0.01] and in cirrhotics, obesity, [64.3% vs. 17.2%, OR = 8.1 (1.9–38.8), p = 0.002] predisposed more to liver injury than those without these . Forty three percent of CLD without cirrhosis presented as acute liver injury and 20% cirrhotics presented with either acute-on-chronic liver failure [5 (11.6%)] or acute decompensation [4 (9%)]. Liver related complications increased (p < 0.05) with stage of liver disease; a Child-Turcotte Pugh score of 9 or more at presentation predicted high mortality [AUROC 0.94, HR = 19.2 (95 CI 2.3–163.3), p < 0.001, sensitivity 85.7% and specificity 94.4%). In decompensated cirrhotics, the liver injury was progressive in 57% patients, with 43% mortality. Rising bilirubin and AST/ALT ratio predicted mortality among cirrhosis patients. Conclusions SARS-Cov-2 infection causes significant liver injury in CLD patients, decompensating one fifth of cirrhosis, and worsening the clinical status of the already decompensated. The CLD patients with diabetes and obesity are more vulnerable and should be closely monitored.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12072-020-10072-8

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 296

Metadata

Authors
Sarin, S. K., Choudhury, A., Lau, G. K., Zheng, M.-H., Ji, D., Abd-Elsalam, S., Hwang, J., Qi, X., Cua, I. H., Suh, J. I., Park, J. G., Putcharoen, O., Kaewdech, A., Piratvisuth, T., Treeprasertsuk, S., Park, S., Wejnaruemarn, S., Payawal, D. A., Baatarkhuu, O., Ahn, S. H., Yeo, C. D., Alonzo, U. R., Chinbayar, T., Loho, I. M., Yokosuka, O., Jafri, W., Tan, S., Soo, L. I., Tanwandee, T., Gani, R., Anand, L., Esmail, E. S., Khalaf, M., Alam, S., Lin, C.-Y., Chuang, W.-L., Soin, A. S., Garg, H. K., Kalista, K., Batsukh, B., Purnomo, H. D., Dara, V. P., Rathi, P., Al Mahtab, M., Shukla, A., Sharma, M. K., Omata, M., & APASL COVID Task Force, A. C. L. I. S. S. (. S.-N. 0.
Venue
Hepatology International
Published
2020-07-04
Volume
14
Issue
5
Pages
690-700
ISSN
  • 1936-0533 (ISSN-L)
  • 1936-0541
OpenAlex
W3038175434
Cited by
296
References
34
FWCI
7.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). https://app.cochat.ai/papers/10.1007/s12072-020-10072-8
The paper
Sarin, S. K., Choudhury, A., Lau, G. K., Zheng, M.-H., Ji, D., Abd-Elsalam, S., Hwang, J., Qi, X., Cua, I. H., Suh, J. I., Park, J. G., Putcharoen, O., Kaewdech, A., Piratvisuth, T., Treeprasertsuk, S., Park, S., Wejnaruemarn, S., Payawal, D. A., Baatarkhuu, O., . . . APASL COVID Task Force, A. C. L. I. S. S. (. S.-N. 0. (2020). Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Hepatology International. https://doi.org/10.1007/s12072-020-10072-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.